Sling banks $123M for an experimental thyroid eye disease pill
Published . Updated .
A confirmatory late-stage study is now also underway for what the startup is positioning as, potentially, the first oral alternative to approved injectables like Amgen's Tepezza and Viridian's Lumvoa.
Directly affected
- AMGN Amgen
Named in this report.
Indirectly affected
- ALLY ALLY FINANCIAL INC
GA selected ALLY as a RELATED security because its canonical security name directly matches this event's themes: financial. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BAC BANK AMERICA CORP
GA selected BAC as a RELATED security because its canonical security name directly matches this event's themes: bank. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BMO BANK MONTREAL MEDIUM
GA selected BMO as a RELATED security because its canonical security name directly matches this event's themes: bank. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- CM CANADIAN IMPERIAL BANK OF CO
GA selected CM as a RELATED security because its canonical security name directly matches this event's themes: bank. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- CRBG COREBRIDGE FINANCIAL INC
GA selected CRBG as a RELATED security because its canonical security name directly matches this event's themes: financial. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- EFC ELLINGTON FINANCIAL INC
GA selected EFC as a RELATED security because its canonical security name directly matches this event's themes: financial. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
A confirmatory late-stage study is now also underway for what the startup is positioning as, potentially, the first oral alternative to approved injectables like Amgen's Tepezza and Viridian's Lumvoa.
Source: BioPharma Dive
Ally Financial (ALLY) since this story, compared with the market
Since the first closing price after “Sling banks $123M for an experimental thyroid eye disease pill,” Ally Financial (ALLY) is -7.56%. The S&P 500 fund (SPY) is +0.52% over the same days, a -8.08% difference versus the market.
Filings that name Ally Financial (ALLY) around 16 Sep 2026
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Ally Financial (ALLY)
Companies tied to this story
- ALLY Ally Financial
Ally Financial (ALLY) is linked, with no stored direction, medium confidence in the 16 Sep 2026 story “Sling banks $123M for an experimental thyroid eye disease pill.” Reason on file: GA selected ALLY as a RELATED security because its canonical security name directly matches this event's themes: financial. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BAC Bank Of America
In “Sling banks $123M for an experimental thyroid eye disease pill,” Bank Of America (BAC) is linked, with no stored direction, medium confidence. Reason on file: GA selected BAC as a RELATED security because its canonical security name directly matches this event's themes: bank. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BMO Bank Of Montreal /Can/
Bank Of Montreal /Can/ (BMO) is linked, with no stored direction, medium confidence in the 16 Sep 2026 story “Sling banks $123M for an experimental thyroid eye disease pill.” Reason on file: GA selected BMO as a RELATED security because its canonical security name directly matches this event's themes: bank. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CM Canadian Imperial Bank Of Commerce /Can/
In “Sling banks $123M for an experimental thyroid eye disease pill,” Canadian Imperial Bank Of Commerce /Can/ (CM) is linked, with no stored direction, medium confidence. Reason on file: GA selected CM as a RELATED security because its canonical security name directly matches this event's themes: bank. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CRBG Corebridge Financial
For “Sling banks $123M for an experimental thyroid eye disease pill,” Corebridge Financial (CRBG) is linked, with no stored direction, medium confidence. Reason on file: GA selected CRBG as a RELATED security because its canonical security name directly matches this event's themes: financial. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- EFC Ellington Financial
For “Sling banks $123M for an experimental thyroid eye disease pill,” Ellington Financial (EFC) is linked, with no stored direction, medium confidence. Reason on file: GA selected EFC as a RELATED security because its canonical security name directly matches this event's themes: financial. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Ally Financial (ALLY)
On 16 Sep 2026, “Sling banks $123M for an experimental thyroid eye disease pill” is the story that connects Ally Financial (ALLY) to this story.
For Ally Financial (ALLY), the reason on file says GA selected ALLY as a RELATED security because its canonical security name directly matches this event's themes: financial. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
A second company, Bank Of America (BAC), is listed for a different reason: GA selected BAC as a RELATED security because its canonical security name directly matches this event's themes: bank. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Price levels for Ally Financial (ALLY)
ALLY traded between 36.18 and 40.33 across 20 sessions. The latest close on file is 37.53. BAC traded between 49.26 and 58.11 across 20 sessions. The latest close on file is 50.39. BMO traded between 159.57 and 177.46 across 20 sessions. The latest close on file is 166.07.
What the saved facts support for Ally Financial (ALLY)
46 out of 100
“Sling banks $123M for an experimental thyroid eye disease pill” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.